AU2002228912A1 - Short peptides from the "a-region" of protein kinases which selectively modulate protein kinase activity - Google Patents
Short peptides from the "a-region" of protein kinases which selectively modulate protein kinase activityInfo
- Publication number
- AU2002228912A1 AU2002228912A1 AU2002228912A AU2891202A AU2002228912A1 AU 2002228912 A1 AU2002228912 A1 AU 2002228912A1 AU 2002228912 A AU2002228912 A AU 2002228912A AU 2891202 A AU2891202 A AU 2891202A AU 2002228912 A1 AU2002228912 A1 AU 2002228912A1
- Authority
- AU
- Australia
- Prior art keywords
- region
- kinase activity
- short peptides
- selectively modulate
- protein kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000001253 Protein Kinase Human genes 0.000 title 2
- 108060006633 protein kinase Proteins 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/734,520 | 2000-12-11 | ||
| US09/734,520 US20020115173A1 (en) | 2000-12-11 | 2000-12-11 | Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity |
| PCT/US2001/047443 WO2002048336A2 (fr) | 2000-12-11 | 2001-12-11 | Peptides courts provenant de la 'region a' des proteines kinases modulant de maniere selective l'activite des proteines kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002228912A1 true AU2002228912A1 (en) | 2002-06-24 |
Family
ID=24952020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002228912A Abandoned AU2002228912A1 (en) | 2000-12-11 | 2001-12-11 | Short peptides from the "a-region" of protein kinases which selectively modulate protein kinase activity |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20020115173A1 (fr) |
| AU (1) | AU2002228912A1 (fr) |
| WO (1) | WO2002048336A2 (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| US20030219846A1 (en) * | 2002-02-28 | 2003-11-27 | Pfizer Inc. | Assay for activity of the ActRIIB kinase |
| EP1651671A2 (fr) | 2003-07-30 | 2006-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Agonistes d'epitope de cellule t epha2 t et utilisations correspondantes |
| ES2421139T3 (es) | 2003-07-30 | 2013-08-29 | Rigel Pharmaceuticals, Inc. | Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias |
| US7485297B2 (en) * | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
| CA2535171A1 (fr) * | 2003-08-12 | 2005-03-03 | Dyax Corp. | Ligands se fixant au tie 1 |
| US7871610B2 (en) * | 2003-08-12 | 2011-01-18 | Dyax Corp. | Antibodies to Tie1 ectodomain |
| CN1956994B (zh) * | 2004-03-31 | 2012-09-05 | 特许技术开发株式会社 | 上皮系细胞增殖促进剂 |
| US8158586B2 (en) | 2005-04-11 | 2012-04-17 | Pharmagap Inc. | Inhibitors of protein kinases and uses thereof |
| US7491732B2 (en) | 2005-06-08 | 2009-02-17 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
| US20070203161A1 (en) * | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| WO2007098507A2 (fr) | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions et méthodes destinées à l'inhibition de la voie jak |
| WO2008089070A2 (fr) * | 2007-01-12 | 2008-07-24 | Dyax Corp. | Polythérapie pour le traitement du cancer |
| MX2010008926A (es) | 2008-02-15 | 2011-02-23 | Rigel Pharmaceuticals Inc | Compuestos de pirimidin-2-amina y su uso como inhibidores de jak cinasas. |
| NZ589315A (en) | 2008-04-16 | 2012-11-30 | Portola Pharm Inc | 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors |
| US8138339B2 (en) | 2008-04-16 | 2012-03-20 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| NZ588830A (en) | 2008-04-22 | 2012-11-30 | Portola Pharm Inc | Inhibitors of protein kinases |
| US9102625B2 (en) | 2010-11-01 | 2015-08-11 | Portola Pharmaceuticals, Inc. | Nicotinamides as JAK kinase modulators |
| US9067988B2 (en) | 2010-12-01 | 2015-06-30 | Alderbio Holdings Llc | Methods of preventing or treating pain using anti-NGF antibodies |
| US9539324B2 (en) | 2010-12-01 | 2017-01-10 | Alderbio Holdings, Llc | Methods of preventing inflammation and treating pain using anti-NGF compositions |
| NZ611076A (en) | 2010-12-01 | 2015-09-25 | Alderbio Holdings Llc | Anti-ngf compositions and use thereof |
| US9884909B2 (en) | 2010-12-01 | 2018-02-06 | Alderbio Holdings Llc | Anti-NGF compositions and use thereof |
| US9078878B2 (en) | 2010-12-01 | 2015-07-14 | Alderbio Holdings Llc | Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 |
| US11214610B2 (en) | 2010-12-01 | 2022-01-04 | H. Lundbeck A/S | High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris |
| WO2012087943A2 (fr) * | 2010-12-20 | 2012-06-28 | The Regents Of The University Of Michigan | Inhibiteurs de l'interaction de liaison entre le récepteur du facteur de croissance épidermique et la protéine de choc thermique 90 |
| EP2782579B1 (fr) | 2011-11-23 | 2019-01-02 | Portola Pharmaceuticals, Inc. | Inhibiteurs de de la pyrazine kinase |
| US9676756B2 (en) | 2012-10-08 | 2017-06-13 | Portola Pharmaceuticals, Inc. | Substituted pyrimidinyl kinase inhibitors |
| CN115443150A (zh) | 2019-12-17 | 2022-12-06 | 德克萨斯大学系统董事会 | 新型ddr1抗体和其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174993B1 (en) * | 1997-05-21 | 2001-01-16 | The Children's Medical Center Corp. | Short peptides which selectively modulate the activity of serine/threonine kinases |
| US6723694B1 (en) * | 1997-05-21 | 2004-04-20 | The Children's Medical Center Corp. | Short peptides which selectively modulate intracellular signalling |
| AU6059099A (en) * | 1998-09-25 | 2000-04-17 | Children's Medical Center Corporation | Short peptides which selectively modulate the activity of protein kinases |
| GB9902696D0 (en) * | 1999-02-09 | 1999-03-31 | Medical Res Council | Screening methods |
-
2000
- 2000-12-11 US US09/734,520 patent/US20020115173A1/en not_active Abandoned
-
2001
- 2001-12-11 WO PCT/US2001/047443 patent/WO2002048336A2/fr not_active Ceased
- 2001-12-11 US US10/012,034 patent/US20020137141A1/en not_active Abandoned
- 2001-12-11 AU AU2002228912A patent/AU2002228912A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020137141A1 (en) | 2002-09-26 |
| WO2002048336A2 (fr) | 2002-06-20 |
| US20020115173A1 (en) | 2002-08-22 |
| WO2002048336A3 (fr) | 2003-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002228912A1 (en) | Short peptides from the "a-region" of protein kinases which selectively modulate protein kinase activity | |
| IL142828A0 (en) | Short peptides which selectively modulate the activity of protein kinases | |
| AU5468499A (en) | 3-methylidenyl-2-indolinone modulators of protein kinase | |
| AU1371999A (en) | Benzothiazole protein tyrosine kinase inhibitors | |
| AU5173400A (en) | Protein kinases | |
| AU8681798A (en) | Imidazoquinoxaline protein tyrosine kinase inhibitors | |
| AU8681698A (en) | Imidazoquinoxaline protein tyrosine kinase inhibitors | |
| AU2002334355A1 (en) | Protein tyrosine kinase inhibitors | |
| AU6411698A (en) | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | |
| AU8154798A (en) | Disease associated protein kinases | |
| AU2437900A (en) | Piperidinylquinolines as protein tyrosine kinase inhibitors | |
| AU6882598A (en) | Protein kinase inhibitor | |
| AU6181000A (en) | Novel genes encoding protein kinase/protein phosphatase | |
| AU7829700A (en) | Protein phosphatase and kinase proteins | |
| AU6163398A (en) | Identification of inhibitors of protein tyrosine kinase 2 | |
| AU6180900A (en) | Novel genes encoding protein kinase/protein phosphatase | |
| EP1012150A4 (fr) | Composes d'heteroarylcarboxamide actifs contre les etats pathologiques lies aux proteine tyrosine kinases | |
| AU2002247063A1 (en) | Antisense modulation of casein kinase 2-beta expression | |
| AU6049399A (en) | Serine/threonine protein kinases | |
| AU2001287914A1 (en) | Protein kinase regulation | |
| AU2591299A (en) | Human protein kinase c inhibitor | |
| AU3566200A (en) | Human signal transduction serine/threonine protein kinase | |
| GB9803399D0 (en) | Protein kinase c | |
| AU2001279090A1 (en) | Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases | |
| GB0007915D0 (en) | Protein kinase assay |